Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Travel vaccines industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Composition trends
2.1.4 Disease type trends
2.1.5 Application trends
Chapter 3 Travel Vaccines Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing travel & tourism
3.2.1.2 Increasing awareness about vaccine-preventable diseases among travelers
3.2.1.3 Initiatives by governments and other organizations to enhance travel safety
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of travel vaccinations
3.2.2.2 Side effects associated with travel vaccines
3.3 Growth potential analysis
3.3.1 By composition
3.3.2 By disease type
3.3.3 By application
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Travel Vaccines Market, By Composition, 2018 - 2032 (USD Million)
5.1 Key trends, by composition
5.2 Mono vaccines
5.3 Combination vaccines
Chapter 6 Travel Vaccines Market, By Disease Type, 2018 – 2032 (USD Million)
6.1 Key trends, by disease type
6.2 Hepatitis A
6.3 Hepatitis B
6.4 Influenza
6.5 Diphtheria pertussis tetanus (DPT)
6.6 Rabies
6.7 Yellow fever
6.8 Typhoid
6.9 Measles and mumps
6.10 Meningococcal
6.11 Other disease vaccines
Chapter 7 Travel Vaccines Market, By Application, 2018 - 2032 (USD Million)
7.1 Key trends, by application
7.2 Outbound travel
7.3 Domestic travel
Chapter 8 Travel Vaccines Market, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 GSK plc
9.2 Sanofi
9.3 Janssen Pharmaceuticals Inc.
9.4 Pfizer Inc.
9.5 CSL Ltd.
9.6 Qiagen N.V.
9.7 AstraZeneca
9.8 F. Hoffmann-La Roche Ltd
9.9 Abbott Laboratories
9.10 Valneva Inc
